Affimed NV (AFMD)
5.31
-0.13
(-2.39%)
USD |
NASDAQ |
May 17, 16:00
5.31
0.00 (0.00%)
After-Hours: 20:00
Affimed Free Cash Flow: -123.42M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -123.42M |
| September 30, 2023 | -132.44M |
| June 30, 2023 | -125.27M |
| March 31, 2023 | -115.06M |
| December 31, 2022 | -111.35M |
| September 30, 2022 | -110.46M |
| June 30, 2022 | -123.66M |
| March 31, 2022 | -118.53M |
| December 31, 2021 | -107.01M |
| September 30, 2021 | -52.48M |
| June 30, 2021 | -29.77M |
| March 31, 2021 | -24.86M |
| December 31, 2020 | -22.66M |
| September 30, 2020 | -40.45M |
| June 30, 2020 | -46.82M |
| March 31, 2020 | -37.11M |
| December 31, 2019 | -34.18M |
| September 30, 2019 | 51.83M |
| June 30, 2019 | 53.72M |
| March 31, 2019 | 50.87M |
| December 31, 2018 | 57.53M |
| Date | Value |
|---|---|
| September 30, 2018 | -34.24M |
| June 30, 2018 | -33.37M |
| March 31, 2018 | -30.58M |
| December 31, 2017 | -29.69M |
| September 30, 2017 | -32.07M |
| June 30, 2017 | -31.28M |
| March 31, 2017 | -34.12M |
| December 31, 2016 | -35.84M |
| September 30, 2016 | -33.25M |
| June 30, 2016 | -31.48M |
| March 31, 2016 | -25.94M |
| December 31, 2015 | -20.88M |
| September 30, 2015 | -23.68M |
| June 30, 2015 | -18.35M |
| March 31, 2015 | -20.12M |
| December 31, 2014 | -14.43M |
| September 30, 2014 | -10.17M |
| June 30, 2014 | -4.367M |
| March 31, 2014 | -3.461M |
| December 31, 2013 | -7.756M |
Free Cash Flow Range, Past 5 Years
-132.44M
Minimum
Sep 2023
53.72M
Maximum
Jun 2019
-65.79M
Average
-52.48M
Median
Sep 2021
Free Cash Flow Benchmarks
| InflaRx NV | -45.89M |
| MorphoSys AG | -- |
| BioNTech SE | 5.344B |
| Immatics NV | -29.05M |
| CureVac NV | -349.78M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -27.02M |
| Cash from Investing (Quarterly) | 1.755M |
| Cash from Financing (Quarterly) | -1.482M |
| Free Cash Flow Per Share (Quarterly) | -1.842 |
| Free Cash Flow to Equity (Quarterly) | -26.63M |
| Free Cash Flow to Firm (Quarterly) | -27.55M |
| Free Cash Flow Yield | -155.6% |